Daffodills Pharmaceuticals Limited, a active public limited company, was established on 28 May 1985 in Meerut, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233UP1985PLC007205. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.23 Cr.
Formerly known as Daffodills Pharmaceutical Private Limited. It upholds a compliant status. Employing 11 professional, Its leadership includes Pranav Chaudhary (Director), Prateek Chaudhary (Director), Prabhat Kumar Rai (Whole-Time Director). Past directors included Amit Dhaka, Narender Chaudhary, Surender Chaudhary. It holds ₹16.93 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, 250001.
U24233UP1985PLC007205
007205
28 May 1985
₹5.50 Cr
₹3.23 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Daffodills Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranav Chaudhary | Director | 22 Feb 2012 | Current |
| Prateek Chaudhary | Director | 22 Feb 2012 | Current |
| Prabhat Kumar Rai | Whole-Time Director | 30 Jul 2019 | Current |
| Kunwar Krishanpal Singh | Whole-Time Director | 30 Jul 2019 | Current |
| Prashant Chaudhry | Director | 02 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2018 | Past |
| Pramod Abcsdd | Director | 23 Feb 2012 | Past |
| Pramod Abcsdd | Director | 23 Feb 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daffodills Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.92% increase. The company also saw a substantial improvement in profitability, with a 11.89% increase in profit. The company's net worth moved up by a moderate rise of 5.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Daffodills Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹169,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2025 | State Bank Of India | ₹6.95 Cr | Open |
| 26 May 2025 | Axis Bank Limited | ₹4.60 Cr | Open |
| 20 Sep 2018 | Axis Bank Limited | ₹5.00 Cr | Open |
| 14 Oct 1995 | U. P. Financial Corporation | ₹3.80 M | Open |
Explore comprehensive loan charge details -
Daffodills Pharmaceuticals has a workforce of 11 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daffodills Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodills Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with State Bank Of India amounted to Rs. 6.95 Cr with Charge ID 101161572 was registered on 03 Oct 2025. was completed.
A charge with Axis Bank Limited amounted to Rs. 4.60 Cr with Charge ID 101120639 was registered on 26 May 2025. was recorded as a recent event.
Daffodills Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Daffodills Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Prabhat Kumar Rai was appointed as a Whole-time director was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 6 years 4 months . was documented.
Progress on Kunwar Krishanpal Singh was appointed as a Whole-time director was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 6 years 4 months . was documented.
The CIN of Daffodills Pharmaceuticals Limited is U24233UP1985PLC007205.
Daffodills Pharmaceuticals Limited is headquartered at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, 250001.
Daffodills Pharmaceuticals Limited was incorporated on 28 May 1985.
The current directors of Daffodills Pharmaceuticals Limited are
The primary industry of Daffodills Pharmaceuticals Limited is Manufacturing.
Daffodills Pharmaceuticals Limited is unlisted.
The authorized capital of Daffodills Pharmaceuticals Limited is ₹5.50 Cr, and the paid-up capital is ₹3.23 Cr.
The compliance status of Daffodills Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX